Home
SPRO
SPRO News

Latest Spero Therapeutics Inc. (SPRO) News on November 20, 2025

Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update

GlobeNewswire

7 days ago

Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update

Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025

GlobeNewswire

16 days ago

Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025

3 Promising Penny Stocks With Market Caps Over $20M

Simply Wall St.

16 days ago

3 Promising Penny Stocks With Market Caps Over $20M

MT Newswires

a month ago

Spero Therapeutics Reports Primary Endpoint Success in Urinary Tract Infections Phase 3 Study; Shares Jump Premarket

PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)

GlobeNewswire

a month ago

PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)

Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek

GlobeNewswire

a month ago

Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek

October 2025's Promising Penny Stocks To Consider

Simply Wall St.

a month ago

October 2025's Promising Penny Stocks To Consider

While institutions own 20% of Spero Therapeutics, Inc. (NASDAQ:SPRO), retail investors are its largest shareholders with 54% ownership

Simply Wall St.

5 months ago

While institutions own 20% of Spero Therapeutics, Inc. (NASDAQ:SPRO), retail investors are its largest shareholders with 54% ownership

Spero Therapeutics Jumps as Oral Carbapenem Hits Phase 3 Milestone

Insider Monkey

6 months ago

Spero Therapeutics Jumps as Oral Carbapenem Hits Phase 3 Milestone

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal

Zacks

6 months ago

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal

Spero Therapeutics And 2 Other Promising Penny Stocks To Watch

Simply Wall St.

6 months ago

Spero Therapeutics And 2 Other Promising Penny Stocks To Watch

MT Newswires

6 months ago

Top Midday Gainers

MT Newswires

6 months ago

Spero Therapeutics, GSK Say Phase 3 Trial of Oral UTI Drug Meets Main Goal; Spero Shares Jump

GSK-licensed antibiotic meets goal in late-stage study

BioPharma Dive

6 months ago

GSK-licensed antibiotic meets goal in late-stage study

Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee

GlobeNewswire

6 months ago

Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee

Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Misses Revenue Estimates

Zacks

6 months ago

Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Misses Revenue Estimates

Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update

GlobeNewswire

6 months ago

Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update

Spero Therapeutics Inc (SPRO) Q1 2025: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

6 months ago

Spero Therapeutics Inc (SPRO) Q1 2025: Everything You Need To Know Ahead Of Earnings

Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025

GlobeNewswire

7 months ago

Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025

Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

GlobeNewswire

7 months ago

Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

We're Keeping An Eye On Spero Therapeutics' (NASDAQ:SPRO) Cash Burn Rate

Simply Wall St.

8 months ago

We're Keeping An Eye On Spero Therapeutics' (NASDAQ:SPRO) Cash Burn Rate

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Spero Therapeutics Inc Earnings Call

Spero Therapeutics Inc (SPRO) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges ...

GuruFocus.com

8 months ago

Spero Therapeutics Inc (SPRO) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges ...

Spero Therapeutics, Inc. (SPRO) Reports Q4 Loss, Tops Revenue Estimates

Zacks

8 months ago

Spero Therapeutics, Inc. (SPRO) Reports Q4 Loss, Tops Revenue Estimates

Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update

GlobeNewswire

8 months ago

Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update

Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025

GlobeNewswire

8 months ago

Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025

UPDATE – Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

GlobeNewswire

9 months ago

UPDATE – Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

GlobeNewswire

9 months ago

Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

Spero Therapeutics (SPRO) Upgraded to Buy: Here's What You Should Know

Zacks

10 months ago

Spero Therapeutics (SPRO) Upgraded to Buy: Here's What You Should Know

Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes

GlobeNewswire

10 months ago

Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes

Here's Why Arcutis Stock More Than Doubled in Market Value in One Year

Zacks

a year ago

Here's Why Arcutis Stock More Than Doubled in Market Value in One Year

CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA

Zacks

a year ago

CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA

Neumora Stock Hits Record Low on Depression Drug Study Failure

Zacks

a year ago

Neumora Stock Hits Record Low on Depression Drug Study Failure

EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study

Zacks

a year ago

EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study

Spero Therapeutics (SPRO) Loses -9.32% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

a year ago

Spero Therapeutics (SPRO) Loses -9.32% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday

Zacks

a year ago

Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday

JANX Stock Hits Record High on Prostate Cancer Study Data

Zacks

a year ago

JANX Stock Hits Record High on Prostate Cancer Study Data

PTCT Stock Soars on Licensing Deal With NVS for Huntington's Therapy

Zacks

a year ago

PTCT Stock Soars on Licensing Deal With NVS for Huntington's Therapy

Grifols Stock Declines After Brookfield Drops Buyout Offer

Zacks

a year ago

Grifols Stock Declines After Brookfield Drops Buyout Offer

JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer

Zacks

a year ago

JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

Zacks

a year ago

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

FATE Presents Encourgaing Data From Lupus Study, Stock Gains

Zacks

a year ago

FATE Presents Encourgaing Data From Lupus Study, Stock Gains

CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC

Zacks

a year ago

CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC

TenNor’s Phase III antibiotic trial meets all primary endpoints

Clinical Trials Arena

a year ago

TenNor’s Phase III antibiotic trial meets all primary endpoints

CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC

Zacks

a year ago

CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC

Spero Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

Spero Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Lags Revenue Estimates

Zacks

a year ago

Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Lags Revenue Estimates

Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update

GlobeNewswire

a year ago

Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update

What To Expect From Spero Therapeutics Inc (SPRO) Q3 2024 Earnings

GuruFocus.com

a year ago

What To Expect From Spero Therapeutics Inc (SPRO) Q3 2024 Earnings

Spero Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 14, 2024

GlobeNewswire

a year ago

Spero Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 14, 2024

Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth

Zacks

a year ago

Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth

Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates

Zacks

a year ago

Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates

Spero’s stock slides after antibiotic flops in Phase II trial

Pharmaceutical Technology

a year ago

Spero’s stock slides after antibiotic flops in Phase II trial

MT Newswires

a year ago

Spero Therapeutics Suspends Program for Pulmonary Disease Drug; Plans to Cut Workforce by 39%

Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business Update

GlobeNewswire

a year ago

Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business Update

Spero Therapeutics, Inc. (NASDAQ:SPRO) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Simply Wall St.

a year ago

Spero Therapeutics, Inc. (NASDAQ:SPRO) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024

GlobeNewswire

a year ago

Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024

MT Newswires

a year ago

Spero Therapeutics Phase 1 Trial of Lung Disease Treatment Backs Further Assessment

Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy

GlobeNewswire

a year ago

Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy

Spero Therapeutics to Present at Upcoming September Investor Conferences

GlobeNewswire

a year ago

Spero Therapeutics to Present at Upcoming September Investor Conferences

Spero Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

Spero Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Thomson Reuters StreetEvents

a year ago

Q2 2024 Spero Therapeutics Inc Earnings Call

Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Tops Revenue Estimates

Zacks

a year ago

Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Tops Revenue Estimates

Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024

GlobeNewswire

a year ago

Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?

Zacks

a year ago

Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference

GlobeNewswire

2 years ago

Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference

Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update

GlobeNewswire

2 years ago

Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update

Shareholders in Spero Therapeutics (NASDAQ:SPRO) are in the red if they invested three years ago

Simply Wall St.

2 years ago

Shareholders in Spero Therapeutics (NASDAQ:SPRO) are in the red if they invested three years ago

Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024

GlobeNewswire

2 years ago

Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 years ago

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

14 Cheap Penny Stocks to Buy According to Analysts

Insider Monkey

2 years ago

14 Cheap Penny Stocks to Buy According to Analysts

Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.

2 years ago

Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript

Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Simply Wall St.

2 years ago

Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Spero Therapeutics Inc Earnings Call

Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates

Zacks

2 years ago

Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates

Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update

GlobeNewswire

2 years ago

Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update

Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024

GlobeNewswire

2 years ago

Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024

Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections

GlobeNewswire

2 years ago

Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections

Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference

GlobeNewswire

2 years ago

Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference

Spero Therapeutics Inc CEO Sath Shukla Sells 75,994 Shares

GuruFocus.com

2 years ago

Spero Therapeutics Inc CEO Sath Shukla Sells 75,994 Shares

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 years ago

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quest Resource Holding Corporation's (NASDAQ:QRHC) top owners are retail investors with 36% stake, while 21% is held by institutions

Simply Wall St.

2 years ago

Quest Resource Holding Corporation's (NASDAQ:QRHC) top owners are retail investors with 36% stake, while 21% is held by institutions

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

Insider Monkey

2 years ago

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

Dow Jones Futures: Microsoft, Apple Lead Earnings Tsunami; What To Do Now

Investor's Business Daily

2 years ago

Dow Jones Futures: Microsoft, Apple Lead Earnings Tsunami; What To Do Now

Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know

Zacks

2 years ago

Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

PR Newswire

2 years ago

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

Bright Health Group, Inc.'s (NYSE:BHG) largest shareholders are private equity firms who were rewarded as market cap surged US$33m last week

Simply Wall St.

2 years ago

Bright Health Group, Inc.'s (NYSE:BHG) largest shareholders are private equity firms who were rewarded as market cap surged US$33m last week

11 Hyper-Growth Stocks Billionaires Are Loading Up On

Insider Monkey

2 years ago

11 Hyper-Growth Stocks Billionaires Are Loading Up On

Xiao-I (NASDAQ: AIXI) and ABB (SIX: ABBN) Forge Strategic Partnership to Drive Industrial Digital Intelligence Advancement with Hua Zang Universal Large Language Model

PR Newswire

2 years ago

Xiao-I (NASDAQ: AIXI) and ABB (SIX: ABBN) Forge Strategic Partnership to Drive Industrial Digital Intelligence Advancement with Hua Zang Universal Large Language Model

Virco Manufacturing Corporation (VIRC) Hits Fresh High: Is There Still Room to Run?

Zacks

2 years ago

Virco Manufacturing Corporation (VIRC) Hits Fresh High: Is There Still Room to Run?

Spotting Winners: Zevia PBC (NYSE:ZVIA) And Beverages and Alcohol Stocks In Q3

StockStory

2 years ago

Spotting Winners: Zevia PBC (NYSE:ZVIA) And Beverages and Alcohol Stocks In Q3

Chuck Royce Increases Stake in Intevac Inc

GuruFocus.com

2 years ago

Chuck Royce Increases Stake in Intevac Inc

Red Robin (RRGB) Stock Drops Despite Market Gains: Important Facts to Note

Zacks

2 years ago

Red Robin (RRGB) Stock Drops Despite Market Gains: Important Facts to Note

Zacks Small Cap Research

2 years ago

AIXI: Initiating Coverage – The AI hype cycle subsides but opportunities and challenges lie ahead in 2024

SelectQuote to Release Fiscal Second Quarter 2024 Earnings on February 7

Business Wire

2 years ago

SelectQuote to Release Fiscal Second Quarter 2024 Earnings on February 7

D-Wave Announces 1,200+ Qubit Advantage2™ Prototype in New, Lower-Noise Fabrication Stack, Demonstrating 20x Faster Time-to-Solution on Important Class of Hard Optimization Problems

Business Wire

2 years ago

D-Wave Announces 1,200+ Qubit Advantage2™ Prototype in New, Lower-Noise Fabrication Stack, Demonstrating 20x Faster Time-to-Solution on Important Class of Hard Optimization Problems

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

StockStory

2 years ago

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

Share on Social Networks: